JP2024543013A5 - - Google Patents
Info
- Publication number
- JP2024543013A5 JP2024543013A5 JP2024525592A JP2024525592A JP2024543013A5 JP 2024543013 A5 JP2024543013 A5 JP 2024543013A5 JP 2024525592 A JP2024525592 A JP 2024525592A JP 2024525592 A JP2024525592 A JP 2024525592A JP 2024543013 A5 JP2024543013 A5 JP 2024543013A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- atoms
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273370P | 2021-10-29 | 2021-10-29 | |
| US63/273,370 | 2021-10-29 | ||
| PCT/US2022/078835 WO2023077040A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543013A JP2024543013A (ja) | 2024-11-19 |
| JP2024543013A5 true JP2024543013A5 (enExample) | 2025-10-31 |
Family
ID=84785201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525592A Pending JP2024543013A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250268903A1 (enExample) |
| EP (1) | EP4423058A1 (enExample) |
| JP (1) | JP2024543013A (enExample) |
| KR (1) | KR20240099355A (enExample) |
| CN (1) | CN118451058A (enExample) |
| WO (1) | WO2023077040A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025031481A1 (zh) * | 2023-08-10 | 2025-02-13 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| WO2025077841A1 (zh) * | 2023-10-13 | 2025-04-17 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
| US20250197413A1 (en) | 2023-12-15 | 2025-06-19 | Eli Lilly And Company | Rxfp1 receptor agonists |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE216580T1 (de) | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
| ES2929283T3 (es) * | 2012-05-04 | 2022-11-28 | Us Health | Moduladores del receptor de relaxina 1 |
| MX2023006178A (es) * | 2020-12-08 | 2023-06-08 | Astrazeneca Ab | Derivados de acido 4-(2-fluoro-4-metoxi-5-3-(((1-metilciclobutil)m etil)carbamoil)biciclo[2.2.1]heptan-2-il)carbamoil)fenoxi)-1-meti lciclohexano-1-carboxilico y compuestos similares como moduladores de rxfp1 para el tratamiento de insuficiencia cardiaca. |
-
2022
- 2022-10-28 KR KR1020247017528A patent/KR20240099355A/ko active Pending
- 2022-10-28 WO PCT/US2022/078835 patent/WO2023077040A1/en not_active Ceased
- 2022-10-28 US US18/701,276 patent/US20250268903A1/en active Pending
- 2022-10-28 EP EP22835522.8A patent/EP4423058A1/en active Pending
- 2022-10-28 CN CN202280084766.5A patent/CN118451058A/zh active Pending
- 2022-10-28 JP JP2024525592A patent/JP2024543013A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540163A5 (enExample) | ||
| US11110097B2 (en) | Combination therapies for the treatment of alzheimer's disease and related disorders | |
| JP2022533913A5 (enExample) | ||
| JP2024540164A5 (enExample) | ||
| JP2008520589A5 (enExample) | ||
| JP2024522494A5 (enExample) | ||
| JP2024546951A5 (enExample) | ||
| JP2021534108A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2024517942A5 (enExample) | ||
| JP2022529315A5 (enExample) | ||
| JP2011513420A5 (enExample) | ||
| JP2010501584A5 (enExample) | ||
| AU2014340182A1 (en) | Cromolyn derivatives and related methods of imaging and treatment | |
| JP2023535453A5 (enExample) | ||
| JP2012522759A5 (enExample) | ||
| JP2021102643A5 (enExample) | ||
| JP2022545158A5 (enExample) | ||
| JP2008534453A (ja) | 再灌流傷害および再灌流障害の処置のための置換２−チオ−３，５−ジシアノ−４−フェニル−６−アミノピリジンの使用 | |
| JP2019530674A5 (enExample) | ||
| JP2024175025A (ja) | 組織の灌流の増加における使用のためのイノシトールリン酸化合物 | |
| JP2022545159A5 (enExample) | ||
| JP2025501509A5 (enExample) | ||
| JP2022522890A5 (enExample) | ||
| BRPI0720664A2 (pt) | Derivados de mononitrato de isossorbida para o tratamento de hipertensão ocular. |